Unnati Pharmax

Tafero EM Tablet
Composition: Emtricitabine 200mg + Tenofovir Alafenamide 25mg
International Trade Name: Truvada®

Tafero EM Tablet is a high-quality fixed-dose antiretroviral formulation combining Emtricitabine and Tenofovir Alafenamide, a modern generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tafero EM is supplied by trusted pharmaceutical exporters from India to support global HIV prevention and treatment programs, including both therapeutic and prophylactic use.

Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), together with Tenofovir Alafenamide, a novel nucleotide reverse transcriptase inhibitor with improved renal and bone safety profile, provides potent and sustained inhibition of HIV-1 replication. Tafero EM Tablet is primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents and is also widely used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV acquisition in high-risk populations.

Emtricitabine + Tenofovir Alafenamide tablets, Tafero EM tablet, Truvada TAF generic, PrEP HIV medicine, HIV-1 treatment tablets, antiretroviral exporter India, and HIV pharmaceutical manufacturer India.

Tafero EM Tablet is manufactured under stringent GMP and international pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for ART centers, HIV clinics, government prevention programs, international NGOs, and global pharmaceutical distributors.

Spegra Tablet
Composition: Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
International Trade Name: Odefsey®

Spegra Tablet is a premium fixed-dose combination of Dolutegravir, Emtricitabine, and Tenofovir Alafenamide, serving as a high-quality generic equivalent of the internationally recognized Odefsey®. Manufactured in WHO-GMP certified facilities, Spegra is supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment programs.

This combination therapy includes Dolutegravir, an integrase strand transfer inhibitor (INSTI), Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF), a nucleotide reverse transcriptase inhibitor. Together, they provide potent, once-daily suppression of HIV-1 replication, improved immune function, and a convenient single-tablet regimen for adult patients living with HIV.

Dolutegravir + Emtricitabine + Tenofovir Alafenamide tablets, Spegra tablets, Odefsey generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, Indian pharmaceutical exporter, HIV treatment provider India.

Spegra Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Molnulee Capsule
Composition: Molnupiravir 200mg
International Trade Name: Lagevrio®

Molnulee Capsule is a high-quality antiviral medication containing Molnupiravir 200mg, a generic equivalent of the internationally recognized Lagevrio®. Manufactured in WHO-GMP certified facilities, Molnulee is supplied by trusted pharmaceutical exporters from India to support global COVID-19 treatment programs.

Molnupiravir is a nucleoside analog that inhibits SARS-CoV-2 replication by inducing viral RNA mutagenesis. Molnulee 200mg Capsule is primarily indicated for the treatment of mild to moderate COVID-19 in adult patients at high risk of progressing to severe disease, helping to reduce hospitalization and disease severity.

Molnupiravir 200mg capsule, Molnulee capsule, Lagevrio generic, COVID-19 antiviral therapy, oral antiviral treatment, SARS-CoV-2 infection management, Indian pharmaceutical exporter, antiviral medication supplier India.

Molnulee Capsule is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government COVID-19 programs, and international pharmaceutical distributors.

Tavin 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Tavin 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Tavin is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) is a nucleotide reverse transcriptase inhibitor (NRTI) that effectively suppresses viral replication by inhibiting the reverse transcriptase enzyme, helping reduce viral load and prevent disease progression. Tavin 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients as well as for HIV-1 infection in combination with other antiretroviral agents.

Tenofovir Disoproxil Fumarate 300mg tablets, Tavin tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Tavin 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Tafsure 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tafsure 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tafsure is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that provides effective suppression of HBV replication at a lower dose with improved renal and bone safety compared to traditional Tenofovir Disoproxil Fumarate (TDF). Tafsure 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tafsure tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tafsure 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

TAFNAT 25 mg Tablets
Composition: Tenofovir Alafenamide 25 mg
International Trade Name: Vemlidy®

TAFNAT 25 mg Tablets is a high-quality Tenofovir Alafenamide (TAF) 25 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Vemlidy®. Manufactured in WHO-GMP certified facilities, TAFNAT Tablets are supplied by reliable pharmaceutical exporters from India, supporting global treatment programs for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) that selectively targets HBV replication in hepatocytes, providing effective viral suppression with improved safety and reduced impact on kidney function and bone mineral density compared to conventional Tenofovir formulations. TAFNAT 25 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection.

Keywords: Tenofovir Alafenamide 25 mg tablet, TAFNAT tablet, Vemlidy biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

TAFNAT 25 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Tenohep AF 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tenohep AF 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tenohep AF is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tenohep AF 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tenohep AF tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tenohep AF 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Ricovir 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Ricovir 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Ricovir Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Ricovir 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Ricovir tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Ricovir 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Treavir 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Treavir 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Treavir is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Treavir 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Treavir tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Treavir 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Tenolam Tablets
Composition: Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Combivir® / Truvada® (depending on regional reference)

Tenolam Tablets is a high-quality fixed-dose combination of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg, a trusted antiviral therapy for HIV-1 and chronic hepatitis B virus (HBV) infections. Manufactured in WHO-GMP certified facilities, Tenolam Tablets are supplied by reputable pharmaceutical exporters from India, supporting global antiretroviral treatment programs with a convenient once-daily dosing regimen.

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively inhibit viral replication, help maintain immune function, and reduce disease progression. Tenolam Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for the management of chronic hepatitis B infection.

Keywords: Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg tablet, Tenolam tablet, fixed-dose combination, HIV treatment, chronic hepatitis B management, antiviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Tenolam Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenof EM Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg + Emtricitabine 200mg
International Trade Name: Truvada®

Tenof EM Tablet is a high-quality fixed-dose combination of Tenofovir Disoproxil Fumarate and Emtricitabine, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tenof EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Tenofovir Disoproxil Fumarate (TDF), a nucleotide reverse transcriptase inhibitor, and Emtricitabine (FTC), a nucleoside reverse transcriptase inhibitor. Together, they provide potent suppression of HIV-1 replication, reduce viral load, and help improve immune function in adult patients.

Tenofovir Disoproxil Fumarate + Emtricitabine tablets, Tenof EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Tenof EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Ricovir EM Tablets
Composition: Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Truvada®

Ricovir EM Tablets is a high-quality fixed-dose combination of Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate 300 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Truvada®. Manufactured in WHO-GMP certified facilities, Ricovir EM Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs and pre-exposure prophylaxis (PrEP) initiatives.

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Ricovir EM Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for HIV pre-exposure prophylaxis (PrEP) in high-risk populations.

Keywords: Emtricitabine + Tenofovir Disoproxil Fumarate tablet, Ricovir EM tablet, Truvada biosimilar, fixed-dose combination, HIV treatment, HIV PrEP, antiretroviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Ricovir EM Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenvir EM Tablet
Composition: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Truvada®

Tenvir EM Tablet is a high-quality fixed-dose combination of Emtricitabine and Tenofovir Disoproxil Fumarate, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tenvir EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Emtricitabine (a nucleoside reverse transcriptase inhibitor, NRTI) and Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor, NRTI), providing potent suppression of HIV-1 replication, reduction in viral load, and improved immune function in adult patients.

Emtricitabine + Tenofovir Disoproxil Fumarate tablets, Tenvir EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Tenvir EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Taftrio Tablets
Composition: Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
International Trade Name: Biktarvy®

Taftrio Tablets is a high-quality fixed-dose combination of Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Biktarvy®. Manufactured in WHO-GMP certified facilities, Taftrio Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs with a convenient once-daily dosing regimen.

Bictegravir is an integrase strand transfer inhibitor (INSTI), Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Taftrio Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection.

Keywords: Bictegravir + Emtricitabine + Tenofovir Alafenamide tablet, Taftrio tablet, Biktarvy biosimilar, fixed-dose combination, HIV treatment, antiretroviral therapy, NRTI + NtRTI + INSTI combination, pharmaceutical exporter India, HIV medication manufacturer India.

Taftrio Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Viraday Tablet
Composition: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg
International Trade Name: Atripla®

Viraday Tablet is a high-quality fixed-dose combination of Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz, a generic equivalent of the internationally recognized Atripla®. Manufactured in WHO-GMP certified facilities, Viraday is supplied by trusted pharmaceutical exporters from India to support advanced global antiretroviral treatment programs, particularly for HIV-1 infection.

This combination includes Emtricitabine (a nucleoside reverse transcriptase inhibitor), Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor), and Efavirenz (a non-nucleoside reverse transcriptase inhibitor), providing potent suppression of HIV-1 replication, reduction of viral load, and improved immune function in adult patients. The single-tablet regimen offers convenience and adherence benefits for long-term therapy.

Emtricitabine + Tenofovir Disoproxil Fumarate + Efavirenz tablets, Viraday tablets, Atripla generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, Indian pharmaceutical exporter, HIV treatment provider India.

Viraday Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Tafnat EM Tablets
Composition: Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
International Trade Name: Descovy®

Tafnat EM Tablets is a high-quality fixed-dose combination of Emtricitabine 200 mg and Tenofovir Alafenamide (TAF) 25 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Descovy®. Manufactured in WHO-GMP certified facilities, Tafnat EM Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs and pre-exposure prophylaxis (PrEP) initiatives.

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Tafnat EM Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for HIV PrEP in high-risk populations.

Keywords: Emtricitabine + Tenofovir Alafenamide tablet, Tafnat EM tablet, Descovy biosimilar, fixed-dose combination, HIV treatment, HIV PrEP, antiretroviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Tafnat EM Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenof 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Tenof 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Tenof is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Tenof 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Tenof tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Tenof 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Tenofoshiv 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenofoshiv 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenofoshiv Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenofoshiv 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenofoshiv tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenofoshiv 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenvir AF 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tenvir AF 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tenvir AF is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that provides effective suppression of HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tenvir AF 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tenvir AF tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tenvir AF 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tenohep 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenohep 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenohep Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenohep 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenohep tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenohep 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tafero 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tafero 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tafero is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tafero 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tafero tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tafero 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tenolieva 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenolieva 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenolieva Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenolieva 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenolieva tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenolieva 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tentide AF 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tentide AF 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tentide AF is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tentide AF 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tentide AF tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tentide AF 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Taflieva 25 mg Tablets
Composition: Tenofovir Alafenamide 25 mg
International Trade Name: Vemlidy®

Taflieva 25 mg Tablets is a high-quality Tenofovir Alafenamide (TAF) 25 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Vemlidy®. Manufactured in WHO-GMP certified facilities, Taflieva Tablets are supplied by reputable pharmaceutical exporters from India, supporting global treatment programs for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) that selectively targets HBV replication in hepatocytes, providing effective viral suppression with improved safety and reduced impact on kidney function and bone mineral density compared to conventional Tenofovir formulations. Taflieva 25 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection.

Keywords: Tenofovir Alafenamide 25 mg tablet, Taflieva tablet, Vemlidy biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Taflieva 25 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Rivofonet 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Rivofonet 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Rivofonet is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Rivofonet 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Rivofonet tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Rivofonet 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Teravir 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Teravir 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Teravir is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Teravir 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Teravir tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Teravir 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Emtaf-B 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Emtaf-B 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Emtaf-B is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that provides effective suppression of HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Emtaf-B 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Emtaf-B tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Emtaf-B 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Shivtaf 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Hepbest® / Vemlidy®

Shivtaf 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Hepbest® and Vemlidy®. Manufactured in WHO-GMP certified facilities, Shivtaf is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Shivtaf 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Shivtaf tablets, Hepbest / Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Shivtaf 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tenfoplus 25 mg Tablets
Composition: Tenofovir Alafenamide 25 mg
International Trade Name: Vemlidy®

Tenfoplus 25 mg is a high-quality Tenofovir Alafenamide (TAF) 25 mg oral tablet, a biosimilar equivalent of the internationally recognized nucleotide reverse transcriptase inhibitor marketed under the brand name Vemlidy®. Manufactured in WHO-GMP certified facilities, Tenfoplus Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly in chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) selectively targets HBV replication within hepatocytes, providing potent viral suppression with improved renal and bone safety profiles compared to conventional Tenofovir formulations. Tenfoplus 25 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those at risk of progressive liver disease.

Keywords: Tenofovir Alafenamide 25 mg tablet, Tenfoplus tablet, Vemlidy biosimilar, TAF 25 mg price, chronic hepatitis B treatment, antiviral therapy, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenfoplus 25 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Hepdoze 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Hepdoze 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Hepdoze is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Hepdoze 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Hepdoze tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Hepdoze 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Reviro 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Reviro 300 mg is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a biosimilar equivalent of the internationally recognized nucleotide reverse transcriptase inhibitor marketed under the brand name Viread®. Manufactured in WHO-GMP certified facilities, Reviro Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly in HIV-1 infection and chronic hepatitis B virus (HBV) infection.

Tenofovir Disoproxil Fumarate (TDF) effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Reviro 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Reviro tablet, Viread biosimilar, TDF 300 mg price, HIV treatment, chronic hepatitis B treatment, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Reviro 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Hepbest 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Hepbest 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Hepbest is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Hepbest 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Hepbest tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Hepbest 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tavin EM Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg + Emtricitabine 200mg
International Trade Name: Truvada®

Tavin EM Tablet is a high-quality fixed-dose combination of Tenofovir Disoproxil Fumarate and Emtricitabine, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tavin EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor) and Emtricitabine (a nucleoside reverse transcriptase inhibitor), providing potent suppression of HIV-1 replication, reduction of viral load, and improved immune function in adult patients.

Tenofovir Disoproxil Fumarate + Emtricitabine tablets, Tavin EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Tavin EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Forstavir EM Tablet
Composition: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Truvada®

Forstavir EM Tablet is a high-quality fixed-dose combination of Emtricitabine and Tenofovir Disoproxil Fumarate, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Forstavir EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Disoproxil Fumarate (TDF), a nucleotide reverse transcriptase inhibitor. Together, they provide potent suppression of HIV-1 replication, reduction of viral load, and improved immune function in adult patients.

Emtricitabine + Tenofovir Disoproxil Fumarate tablets, Forstavir EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Forstavir EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Teevir Tablets
Composition: Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Atripla®

Teevir is a high-quality fixed-dose combination tablet containing Efavirenz 600 mg, Emtricitabine 200 mg, and Tenofovir Disoproxil Fumarate 300 mg, a biosimilar equivalent of the internationally recognized antiretroviral therapy marketed under the brand name Atripla®. Manufactured in WHO-GMP certified facilities, Teevir Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment programs.

This combination therapy effectively suppresses HIV-1 replication through the complementary actions of Efavirenz (a non-nucleoside reverse transcriptase inhibitor, NNRTI), Emtricitabine (a nucleoside reverse transcriptase inhibitor, NRTI), and Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor, NtRTI), helping maintain immune function and reduce the risk of disease progression. Teevir Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection, offering convenient once-daily dosing in a single tablet.

Keywords: Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate tablet, Teevir tablet, Atripla biosimilar, fixed-dose combination, HIV treatment, antiretroviral therapy, NNRTI + NRTI + NtRTI combination, pharmaceutical exporter India, HIV medication manufacturer India.

Teevir Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenofoshiv EM Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg + Emtricitabine 200mg
International Trade Name: Truvada®

Tenofoshiv EM Tablet is a high-quality fixed-dose combination of Tenofovir Disoproxil Fumarate and Emtricitabine, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tenofoshiv EM is supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment and prevention programs, including HIV-1 therapy and pre-exposure prophylaxis (PrEP).

This combination includes Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor) and Emtricitabine (a nucleoside reverse transcriptase inhibitor). Together, they provide potent suppression of HIV-1 replication, reduction of viral load, and improved immune function in adult patients.

Tenofovir Disoproxil Fumarate + Emtricitabine tablets, Tenofoshiv EM tablets, Truvada generic, HIV antiretroviral therapy, fixed-dose combination ARV, PrEP medication, Indian pharmaceutical exporter, HIV treatment supplier India.

Tenofoshiv EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

TENFOSHIV-EM Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
International Trade Name: Truvada®

TENFOSHIV-EM is a high-quality fixed-dose combination tablet containing Tenofovir Disoproxil Fumarate and Emtricitabine, a bioequivalent version of the internationally recognized antiretroviral therapy marketed under the brand name Truvada®. Manufactured in WHO-GMP certified facilities, TENFOSHIV-EM Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment and prevention programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI), and Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI). Together, they effectively inhibit HIV-1 replication, help maintain immune function, and significantly reduce the risk of disease progression. TENFOSHIV-EM Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents and are also widely used for HIV pre-exposure prophylaxis (PrEP).

Tenofovir Disoproxil Fumarate + Emtricitabine tablets, TENFOSHIV-EM tablet, Truvada biosimilar, HIV treatment, HIV PrEP medicine, antiretroviral therapy, NtRTI + NRTI combination, pharmaceutical exporter India, and HIV medicine manufacturer India.

TENFOSHIV-EM Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government ART and PrEP programs, and international pharmaceutical distributors.

Emtaf Tablets
Composition: Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
International Trade Name: Descovy®

Emtaf is a high-quality fixed-dose combination tablet containing Emtricitabine and Tenofovir Alafenamide, a bioequivalent version of the internationally recognized antiretroviral therapy marketed under the brand name Descovy®. Manufactured in WHO-GMP certified facilities, Emtaf Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment and prevention programs.

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), while Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) with improved renal and bone safety compared to tenofovir disoproxil fumarate. Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Emtaf Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents and are also approved for use in HIV pre-exposure prophylaxis (PrEP) in eligible patient populations.

Emtricitabine + Tenofovir Alafenamide tablets, Emtaf tablet, Descovy biosimilar, HIV treatment, HIV PrEP medicine, antiretroviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, and HIV medicine manufacturer India.

Emtaf Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government ART and PrEP programs, and international pharmaceutical distributors

Trioday Tablet
Composition: Efavirenz 600mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Symfi®

Trioday Tablet is a high-quality fixed-dose antiretroviral formulation combining Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate, a generic equivalent of the internationally recognized Symfi®. Manufactured in WHO-GMP certified facilities, Trioday is supplied by trusted pharmaceutical exporters from India to support large-scale global HIV/AIDS treatment programs, particularly in high-prevalence and resource-limited regions.

Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), together with Lamivudine and Tenofovir Disoproxil Fumarate, both nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), provides potent and sustained suppression of HIV-1 replication. Trioday Tablet is administered as a once-daily regimen and is widely used as a first-line therapy in adult patients living with HIV to reduce viral load, improve immune function, and prevent disease progression.

Efavirenz + Lamivudine + Tenofovir tablets, Trioday tablet, Symfi generic, first-line HIV antiretroviral therapy, fixed-dose combination ARV, HIV/AIDS treatment supplier India, and antiretroviral exporter India.

Trioday Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for ART centers, hospitals, government HIV programs, international NGOs, and global pharmaceutical distributors.

Vianca Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Efavirenz 400 mg
International Trade Name: Atripla®

Vianca is a high-quality fixed-dose combination tablet containing Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz, a biosimilar equivalent of the internationally recognized antiretroviral therapy marketed under the brand name Atripla®. Manufactured in WHO-GMP certified facilities, Vianca Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI), Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), and Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, they act synergistically to suppress HIV-1 replication, preserve immune function, and reduce the risk of disease progression. Vianca Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection, offering convenient once-daily dosing in a single tablet.

Tenofovir Disoproxil Fumarate + Lamivudine + Efavirenz tablets, Vianca tablet, Atripla biosimilar, HIV treatment, antiretroviral fixed-dose combination, NNRTI + NRTI + NtRTI therapy, pharmaceutical exporter India, and HIV medicine manufacturer India.

Vianca Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government ART programs, and international pharmaceutical distributors.